# Brenda D. Gavin

> Brenda D. Gavin is a startup investor at Quaker BioVentures. See 0 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Quaker BioVentures](https://shizune.co/investors/profile/quaker-bioventures)
- Last updated: Aug 2026

Brenda D. Gavin is a startup investor at Quaker BioVentures. Founding Partner of Quaker BioVentures Previously: President of S.R. One, GlaxoSmithKline's venture capital arm, and general partner of EuclidSR Partners, an independent venture capital fund focused on healthcare and information technology. During her tenure with S.R. One, Dr. Gavin was responsible for dozens of venture and strategicinvestments, and she served as a board member or active board observer for many portfolio companies. Board Responsibilities: Celator Pharmaceuticals, Diasome Pharmaceuticals, Tengion, TetraLogic Pharmaceuticals, and Tranzyme Pharma Prior Board Participation: Adolor, MicroMass Communications, Oxis International, Sepracor, Synbiotics, Versicor Other: Serves on the board of the Ben Franklin Technology Partners of Southeastern PA , the Ben Franklin Technology Development Authority, Innovation Philadelphia, BioAdvance, the Penn State University Research Foundation, the International Advisory Board of the Monell Institute and past board member of the National Venture Capital Association. Education: B.S. from Baylor University, Doctor of Veterinary Medicine magna cum laude from the University of Missouri, M.B.A. from the University of Texas – San Antonio

## Contacts

5 contacts available for Brenda D. Gavin: work email, personal email, work phone, personal phone and socials. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-email/brenda-d-gavin?utm_source=investor_profile

## About Quaker BioVentures

VC Fund · Philadelphia, United States

Quaker BioVentures is a venture capital firm investing in life science companies. The firm leads investments across the spectrum of the life science industry, including biopharmaceuticals, medical devices, human diagnostics, specialty pharmaceuticals, and healthcare services. Quaker BioVentures invests in companies at all stages of development,from early stage start-ups to public companies. Founded in 2003, the firm is currently investing Quaker BioVentures II, a $420 million fund formed in 2007. Quaker BioVentures manages over $700 million in committed capital.

5 contacts available at Quaker BioVentures.

| Name | Title | Profile |
| --- | --- | --- |
| Brenda D. Gavin | Partner | — |
| Richard S. Kollender | Partner | — |
| Adele C. Oliva | Partner | — |
| Geeta Vemuri | Partner | https://shizune.co/investors/profile/geeta-vemuri |
| Ira Lubert | Founding Partner | — |

## FAQ

### How do I contact Brenda D. Gavin?

For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co